Back | Next |
home / stock / cerc / cerc message board
Subject | By | Source | When |
---|---|---|---|
News out today read here: Cerecor and | Jcbaby1 | investorshub | 05/26/2020 11:55:35 AM |
looks like they acquired product lines and not | Chrisny73 | investorshub | 04/30/2020 6:26:11 PM |
according to the SEC doc. $AYTU acquired$ CERC | TheFinalCD | investorshub | 04/30/2020 6:03:58 AM |
Yeah. I used to have this under a | tonyjh | investorshub | 04/24/2020 12:52:53 AM |
Looks like this stock took a beating after | Chrisny73 | investorshub | 04/23/2020 7:21:16 PM |
Gnmx aquired by Cerc!! on our way up!!! | StocktonCA | investorshub | 02/06/2020 5:51:23 PM |
$7-$8 coming | sanderburwil | investorshub | 12/11/2019 5:10:21 PM |
This company is going to be exciting soon | jcbaby | investorshub | 08/14/2019 7:52:50 PM |
News: $CERC Cerecor Reports Second Quarter 2019 Results | whytestocks | investorshub | 08/08/2019 8:30:26 PM |
News: $CERC Cerecor Announces Positive Final Results of | whytestocks | investorshub | 07/01/2019 12:20:25 PM |
News: $CERC Cerecor Added to Russell 3000® Index | whytestocks | investorshub | 06/28/2019 4:50:27 PM |
News: $CERC Cerecor Set to Join Russell 3000® Index | whytestocks | investorshub | 06/11/2019 6:10:40 PM |
Anybody out there following this growing company? | FreedFish | investorshub | 11/24/2018 3:35:23 PM |
Beast | JBowsNose | investorshub | 03/07/2018 10:48:59 PM |
$CERC buy 4.93 | stocktrademan | investorshub | 03/03/2018 6:51:52 PM |
$CERC about to Break 52 week high | europtiger | investorshub | 02/19/2018 1:58:59 PM |
Bullish triangle breakout on 15-Feb-2018 | pietro13 | investorshub | 02/16/2018 5:46:23 PM |
Whatever is happening to this market, I'm glad | cash_cow1 | investorshub | 02/06/2018 1:25:34 PM |
Hedge funds loading. | crudeoil24 | investorshub | 01/23/2018 5:25:33 PM |
Weeee | europtiger | investorshub | 01/23/2018 4:34:46 PM |
News, Short Squeeze, Breakout and More Instantly...
Cerecor Inc. Company Name:
CERC Stock Symbol:
NASDAQ Market:
WAYNE, Pa. and ROCKVILLE, Md., July 16, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced that Mittie Doyle, MD, FACR has joined the Company as its Chief Medical Officer. “We are thrilled to have Mittie join and grow our leadership team at an exciting...
Following FDA review, Avalo’s IND application for AVTX-009 is active allowing Avalo to proceed with its Phase 2 trial (LOTUS) to evaluate the efficacy and safety of AVTX-009 in patients with hidradenitis suppurativa WAYNE, Pa. and ROCKVILLE, Md., July 09, 2024 (GLOBE NEWSWIRE) -- Ava...
WAYNE, Pa. and ROCKVILLE, Md., June 17, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) announced today that Garry A. Neil, M.D., Chief Executive Officer and Chairman of the Board, will present on the Novel Immunological Mechanisms for Dermatological Disorders Panel being held at...